17 Apr 2020 --- Probiotics based on Bifidobacteria may be used as a potential treatment for celiac disease, according to new research published in the American Chemical Society journal. Operating in an artificial intestinal environment, the research team analyzed the cytotoxic and inflammatory responses to four different Bifidobacterium strains and found that those from the Bifidobacterium longum strain caused the least harm to intestinal cells in petri dishes. This research comes at the heels of celiac disease advocates such as Coeliac UK scrambling for government support as the COVID-19 outbreak has hampered many charity organizations’ incomes.
